Do Carmo S et al.Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model.Sci Rep 6:34051 (2016).
MacPherson RE et al.Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice.J Appl Physiol (1985) 119:1097-104 (2015).
Song SY et al.Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-?B activation in cultured astrocytes and microglial BV-2 cells.J Neuroinflammation 11:118 (2014).
Jin P et al.Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model.J Neuroinflammation 10:2 (2013).
Barbero-Camps E et al.APP/PS1 mice overexpressing SREBP-2 exhibit combined Aß accumulation and tau pathology underlying Alzheimer's disease.Hum Mol Genet 22:3460-76 (2013).
Kindy MS et al.Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AßPP containing the wild-type ß-secretase site sequence.J Alzheimers Dis 29:827-40 (2012).
Hook G et al.The cysteine protease inhibitor, E64d, reduces brain amyloid-ß and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ß-secretase activity.J Alzheimers Dis 26:387-408 (2011).
Wen L et al.VPS35 haploinsufficiency increases Alzheimer's disease neuropathology.J Cell Biol 195:765-79 (2011).
Cui J et al.Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70.J Neurosci 31:16227-40 (2011).